Skip to main content
Springer logoLink to Springer
. 2023 Nov 1;45(4):1507–1514. doi: 10.1007/s10072-023-07157-1

Content overlap of 91 dystonia symptoms among the seven most commonly used cervical dystonia scales

Adrian Andrzej Chrobak 1, Jakub Rusinek 2, Małgorzata Dec-Ćwiek 3, Karolina Porębska 3, Marcin Siwek 4,✉
PMCID: PMC10943139  PMID: 37910323

Abstract

Introduction

Dystonia is a movement disorder characterized by sustained or intermittent muscle contractions. Cervical dystonia (CD) is the most common focal dystonia. There are several instruments assessing the symptoms of CD. However, different scales assess different features which may lead to poor patient evaluation.

Aim

The aim of the study was to evaluate the degree of overlap of most often used CD rating scales identified by the literature review.

Methods

A thorough search of the Medline database was conducted in September 2021. Then the frequency of each scale was calculated, and 7 most common scales were included in the content overlap analysis using Jaccard index (0 – no overlap, 1 – full overlap).

Results

Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS), Tsui score, Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS), Cervical Dystonia Impact Profile 58 (CDIP-58), Craniocervical Dystonia Questionnaire 24 (CDQ-24), Cervical Dystonia Severity Rating Scale (CDSS), Cervical Dystonia Severity Rating Scale (DDS) and The Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest) were the most common scales. 91 CD symptoms were distinguished from 134 items used in the scales. The mean overlap among all scales was 0.17. 52 (62%) symptoms were examined by more than one scale. The CIDP-58 captured the highest number of symptoms (63.0%), while the CDSS captured the lowest number (8.0%). None of the symptoms were examined by seven instruments.

Conclusions

There was a very weak overlap among scales. High inconsistency between the scales may lead to highly different dystonia severity assessment in clinical practice. Thus, the instruments should be combined.

Keywords: Cervical dystonia, Clinical scales, Nonmotor symptoms, Movement disorders

Introduction

Dystonia is the third most common movement disorder [1, 2]. It is characterized by sustained or intermittent muscle contractions causing abnormal movements or postures [3]. Currently, dystonia is classified along two axes: clinical characteristics, including age at onset, body distribution, temporal pattern and associated features (additional movement disorders or neurological features); and etiology, which includes nervous system pathology and inheritance [3]. Focal dystonia, which affects only one body region is the most common. Cervical dystonia (CD) is the one with the highest prevalence (from 57/1mln to 4000/1mln) [4]. Over the years multiple scales assessing symptoms and severity of CD were developed. The most popular ones are Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) [5]; Tsui scale [6]; Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) [7]; Cervical Dystonia Impact Profile 58 (CDIP-58) [8]; Craniocervical Dystonia Questionnaire 24 (CDQ-24) [9]; Cervical Dystonia Severity Rating Scale (CDSS) [10]; Dystonia Discomfort Scale (DDS) [11]; The Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest) [12]; Unified Dystonia Rating Scale (UDRS) [13] etc.

However, different scales focus on different features which might result in a poor assessment of disease severity. This problem mainly applies to non-motor symptoms (NMS) of dystonia. For instance, not all of the scales evaluate NMS as some of them were developed before the subject emerged [14]. In recent decades NMS have been the subject of extensive research – the most popular symptoms are: sleep disorders, anxiety and tiredness [15, 16]. Until now, there is no universal tool to assess them. There is a possibility of overlooking the symptoms by using one specific questionnaire.

Eiko Fried (2017) proposed a methodology for evaluating different assessment tools in order to designate the level of overlap of symptoms across the questionnaires [17]. Such analysis might give valuable information about the reproducibility and generalization of findings made by one tool. When the overlap is poor, it might indicate that the symptoms assessed by one tool are idiosyncratic and cannot be found by another tool – putting in doubt the comparability of different studies. Moreover, this methodology has been already used in several different studies [18–21]

The aim of our study was to evaluate the degree of overlap of most often used CD rating scales which were identified by the literature review. Furthermore, we gave recommendations on which scales should be combined to give more specific information about dystonia severity in research.

Materials and methods

Literature review

A thorough search of the Medline database was conducted by one researcher in September 2022. No language or date filters were applied. The query was as follows:

"Torticollis"[MeSH Terms] AND ("scale s"[All Fields] OR "scaled"[All Fields] OR "scaling"[All Fields] OR "scalings"[All Fields] OR "weights and measures"[MeSH Terms] OR ("weights"[All Fields] AND "measures"[All Fields]) OR "weights and measures"[All Fields] OR "scale"[All Fields] OR "scales"[All Fields] OR ("questionnair"[All Fields] OR "questionnaire s"[All Fields] OR "surveys and questionnaires"[MeSH Terms] OR ("surveys"[All Fields] AND "questionnaires"[All Fields]) OR "surveys and questionnaires"[All Fields] OR "questionnaire"[All Fields] OR "questionnaires"[All Fields])).

The inclusion criteria:

  • assessing the symptoms of CD with the usage of a specific scale;

  • patients ≥ 18 years old.

The exclusion criteria:

  • type of article: meta-analyses, systematic review, literature review, case study;

  • usage of scales which are not specific for dystonia assessment;

  • non-cervical types of dystonia;

  • studies developing a scale.

Overall, 196 studies that fulfilled above mentioned criteria were included. Figure 1 presents a flow diagram representing the procedure of finding, excluding and selecting publications for further analyses. The frequency of each scale in the articles was calculated and the seven most common ones were included in the analysis. The decision of choosing the seven most popular used scales was based on the methodology of our previous study [18].

Fig. 1.

Fig. 1

Flowchart of the inclusion process

CD scales

The chosen scales were: 20-item TWSTRS [5]; 7-item Tsui scale [6]; 8-item BFMDRS (8 items because only the part considering neck and disability was analyzed) [7]; 58-item CDIP-58 [8]; 24-item CDQ-24 [9]; 3-item CDSS [10]; 14-item DNMSQuest [12]. Table 1 presents the internal consistency, interrater and test-retest reliability of the tools. Although the frequency of DDS [11] was higher than DNMSQuest (1.5% vs. 1.0%) we decided to include DNMSQuest instead of DDS. Firstly, DDS is a scale that assesses only the patient’s experience related to the disease rated from 0 (no complaints) to 100 (maximum subjective severity of the untreated condition). That is why it is much different from other evaluated scales and thus cannot be compared with them. Secondly, DNMSQuest is a relatively new scale assessing NMS and it is not as well studied as other scales.

Table 1.

Internal consistency interrater and test-retest reliability of analyzed tools. Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS); Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS); Cervical Dystonia Impact Profile 58 (CDIP-58); Craniocervical Dystonia Questionnaire 24 (CDQ-24); Cervical Dystonia Severity Rating Scale (CDSS); The Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest)

Scale Internal consitency Interrater reliability Test-retest reliability
TWSTRS [5] - 0.76—0.98b [22] -
Tsui scale [6] - 0.86c -
BFMDRS [7] - 0.85—0.96c 0.98/0.99c
CDIP-58 [8]  ≥ 0.92a [23] -  ≥ 0.83e [23]
CDQ-24 [9] 0.77—0.89a -  ≥ 0.90e
CDSS [10] -

0.79d for first evaluation

0.86d for second evaluation

0.94d
DNMSQuest [12] - - 0.995e

aCronbach’s alpha

bKendall's coefficient

cCorrelation coefficient

dKappa value

eTest-retest intraclass correlations

Content analysis

Based on the Fried (2017) methodology we adjusted the number of items in each scale [17]. The items were combined if they analyze the same symptom, in order to avoid biasing further analyses. The 8-item BFMDRS was reduced to 6 items. “Dressing”, “hygiene” and “feeding” were combined as one item assessing “limited daily activities”.

58-item CDIP-58 was reduced to 48 items. “Tension in the neck” and “tightness in the neck” were combined as one item assessing unpleasant feeling of tension in the neck. “Aching in shoulders” and “pain in shoulders” were combined as one item assessing pain in shoulders. Similarly to BFMDRS, items such as: “carrying light objects”, “chores”, “cooking”, “getting tired doing light activities”, “cleaning the house”, “limits in type of work”, “heavy chores”, “carrying heavy objects”, “getting tired doing demanding activities” were combined as “limited daily activities”. In our opinion, the analysis of specific activities mentioned in each scale would bias the analysis while those items evaluate a similar issue.

24-item CDQ-24 was adjusted to 23 items. “Feeling down or depressed” and “feeling sad” were combined as “feeling down”.

On the other hand, in TWSTRS we added one item “head movements” to make a comparison more reliable. Original TWSTRS evaluates head movements in detail but it lacks the general category describing them. Therefore, adjusted TWSTRS had 21 items.

After adjusting the scales, the maximum number of 91 symptoms were identified, and they were used in content analysis.

The categorization of items was also based on Fried’s (2017) methodology [17]. Items were treated as disparate if they distinctly differed from each other and they were considered equivalent if they evaluate the same symptom. For instance, “do you have any speech problem?” from DNMSQuest and “speech” from BFMDRS were considered as equivalent as both of them evaluated the same symptom – speech problems. On the other hand, “straining in the neck” and “stiffness in the neck” were not considered equivalent as those are different sensations. The symptom was defined as idiosyncratic if it appears in only one instrument.

Statistical analysis

Firstly, each symptom was evaluated, and the decision was made if it appears specifically in the scale or the symptom is featured generally (indirectly) or is not featured at all. Secondly, the overlap of CD symptoms between the scales was calculated with the use of the Jaccard Index. It is a similarity coefficient for binary data (to run this analysis symptoms were categorized separately from previous analysis as present (1) or not (0) in the scale). The coefficient ranges from 0 (no overlap) to 1 (complete overlap) [17]. It was calculated by su1+u2+s, where s is the number of items two scales share and u1 and u2 stand for the number of items that are unique to each of the scales. Criteria of Jaccard Index power were as follows: very weak 0.00 – 0.19, weak 0.20 – 0.39, moderate 0.40 – 0.59, strong 0.60 – 0.79, very strong 0.80 – 1.00 [17, 24]. Moreover, the symptoms were divided into seven categories: motor symptoms, sensory symptoms, disability, sleep disturbances, gait disturbances, emotions, and social interactions. Then, the rate of symptoms in each category in each scale was calculated. Analyses were conducted with the code supplied in [17] with the usage of R software [25].

Results

From the included articles most commonly used scales were TWSTRS (in 162 articles), Tsui scale (in 40 articles), BFMDRS (in 14 articles), CDIP-58 (in 12 articles), CDQ-24 (in 9 articles), CDSS (in 3 articles), DDS (in 3 articles) and DNMSQuest (in 2 articles). Detailed information about the number of articles in which each scale was used can be found in Fig. 2.

Fig. 2.

Fig. 2

The number of scales in the studies. Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) [5]; Tsui scale [6]; Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) [7]; Cervical Dystonia Impact Profile 58 (CDIP-58) [8]; Craniocervical Dystonia Questionnaire 24 (CDQ-24) [9]; Cervical Dystonia Severity Rating Scale (CDSS) [10]; Dystonia Discomfort Scale (DDS) [11]; The Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest) [12]; Toronto Western Spasmodic Torticollis Rating Scale 2 (TWSTRS-2); Unified Dystonia Rating Scale (UDRS) [13]; Beth Israel Dystonia Screen (BIDS) [26]; Collum-caput concept (COL-CAP) [27]

The analysis extracted 91 distinct CD symptoms (Fig. 3). 52 (62%) symptoms are examined by more than one scale. Whereas none of the symptoms appear in six or seven instruments simultaneously (Table 2). Furthermore, each symptom is present in two instruments on average.

Fig. 3.

Fig. 3

Presence of 91 dystonia symptoms in 7 most commonly used scales. Colored circles indicate that a symptom is directly assessed by the scale, while empty circles indicate that a scale only measures a symptom indirectly

Table 2.

The number of symptoms found in most commonly used scales. For example, 35 items, presenting 38% of all analysed cervical dystonia-related symptoms, are present in one instrument, while none of the items is present in every analysed scale

Number of items Percent of all symptoms Number of instruments
35 38% 1
21 23% 2
26 29% 3
7 8% 4
2 2% 5
0 0% 6
0 0% 7

In Table 3 the analysis of specific, compound and idiosyncratic symptoms can be found. CDIP-58 consists of the highest number of idiosyncratic symptoms (12 – which is 21% of items in this scale). CDSS is the only instrument that has no idiosyncratic symptoms. CDSS also analyses the lowest percentage of symptoms – 8% of 91 distinct symptoms. On the other hand, CDIP-58 examines the highest percentage of symptoms – 63%.

Table 3.

The percentage of the specific, compound and idiosyncratic symptoms gathered in seven analysed tools, as well as the percentage of all 91 disparate items they capture

Scale Specific symptoms Compound symptoms Number of idiosyncratic items: Percent of idiosyncratic items Sum of items: Original number of scale items: Adjusted number of symptoms per scale: Scale captures x% of all 91 disparate items:
TWSTRS 74% 26% 7 26% 27 20 21 30%
Tsui 55% 45% 2 18% 11 7 7 12%
BFMDRS 50% 50% 1 8% 12 8 6 13%
CDIP-58 77% 23% 12 21% 57 58 48 63%
CDQ-24 40% 60% 9 21% 43 24 23 47%
CDSS 43% 57% 0 0% 7 3 3 8%
DNMSQ 28% 72% 4 11% 36 14 14 40%

TWSTRS is the instrument that analyses the highest number of symptoms in the motor symptoms category – 12 (67%) and in the disability category – 10 (91%). CDIP-58 captures the highest number of sensory symptoms, sleep disturbances and gait disturbances (six (43%), four (100%) and nine (100%), respectively). CDQ-24 consists of the highest number of symptoms related to emotions and social interactions (17 (94%) and 13 (76%), respectively). Detailed information about the symptom categories can be found in Table 4.

Table 4.

The number of symptoms in each category examined by each scale. Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS); Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS); Cervical Dystonia Impact Profile 58 (CDIP-58); Craniocervical Dystonia Questionnaire 24 (CDQ-24); Cervical Dystonia Severity Rating Scale (CDSS); The Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest)

Category of symptoms Number of symptoms overall TWSTRS Tsui scale BFMDRS CDIP-58 CDQ-24 CDSS DNMSQuest
Motor symptoms 18 12 (67%) 11 (61%) 1 (6%) 9 (50%) 1 (6%) 7 (39%) 0 (0%)
Sensory symptoms 14 5 (36%) 0 (0%) 0 (0%) 6 (43%) 2 (14%) 0 (0%) 5 (36%)
Disability 11 10 (91%) 0 (0%) 5 (45%) 2 (18%) 8 (73%) 0 (0%) 4 (36%)
Sleep disturbances 4 0 (0%) 0 (0%) 0 (0%) 4 (100%) 2 (50%) 0 (0%) 3 (75%)
Gait disturbances 9 0 (0%) 0 (0%) 6 (67%) 9 (100%) 0 (0%) 0 (0%) 7 (78%)
Emotions 18 0 (0%) 0 (0%) 0 (0%) 15 (83%) 17 (94%) 0 (0%) 16 (89%)
Social interactions 17 0 (0%) 0 (0%) 0 (0%) 12 (71%) 13 (76%) 0 (0%) 1 (6%)

The mean overlap among all scales is 0.17 which is interpreted as a very weak similarity between the instruments [24]. Mean overlaps of single scales range from 0.09 (BFMDRS) to 0.22 (CDIP-58). The mean overlap is very weak for all scales apart from CDIP-58 (weak mean overlap). The overlap among specific scales ranges from 0.00 to 0.64 (Table 5).

Table 5.

Overlap of the item content of 7 dystonia scales. The Jaccard Index ranges from 0 (no overlap) to 1 (total overlap)

TWSTRS TSUI BFMDRS CDIP58 CDQ24 CDSS DNMSQ
TWSTRS 1,00 0,31 0,11 0,14 0,15 0,26 0,09
TSUI 0,31 1,00 0,00 0,11 0,00 0,64 0,00
BFMDRS 0,11 0,00 1,00 0,13 0,06 0,00 0,26
CDIP58 0,14 0,11 0,13 1,00 0,37 0,12 0,45
CDQ24 0,15 0,00 0,06 0,37 1,00 0,00 0,32
CDSS 0,26 0,64 0,00 0,12 0,00 1,00 0,00
DNMSQ 0,09 0,00 0,26 0,45 0,32 0,00 1,00
Mean overlap 0,18 0,18 0,09 0,22 0,15 0,17 0,19

The correlation between the mean Jaccard coefficient of each scale (the mean overlap a scale with all others) and the length of the scale is 0.61 for the number of specific symptoms captured and 0.54 for the adjusted scale length.

Discussion

In our study, we have conducted a literature search and gathered 196 studies from which we have chosen the seven most commonly used instruments examining CD symptoms. According to the literature, TWSTR is the most popular rating tool used in CD research (82.7%). The second one is Tsui scale (20.4%). 91 disparate symptoms were identified. The mean overlap among all tools was very weak (0.17). As presented in Table 2 38% of symptoms were present in only one instrument while none of the symptoms appeared in all of them. What is more, we conducted the analysis of the categories of symptoms which revealed that some scales do not mention specific categories. It can be found that the most popular scale (TWSTRS) mainly focuses on motor symptoms and disability while there are no items evaluating psychological status. Tsui scale and CDSS also analyse only motor disturbances. On the other hand, BFMDRS focuses mainly on gait and disability. There is also a group of scales (CDIP-58, CDQ-24 and DNMSQuest) focusing on NMS, omitting the motor symptoms. Furthermore, we showed there is a moderate correlation between the Jaccard coefficient and the length of the scale showing that scales with a bigger amount of items have higher level of similarity to other questionnaires.

To our best knowledge, this is the first study to analyse the content overlap of the scales used in CD research. Previously published comparisons of scales focused on the clinical applicability, validity and descriptive analysis of the symptoms measured by the scales [28–30]. In some studies, CD symptoms were examined by more than one scale. For instance, Tarsy used TWSTRS and Tsui scale to assess the dystonia severity for the same patients in the study about botulinum toxin efficacy and found a significant positive correlation between the reduction of two scales scores after the treatment [31]. Considering our analysis, those scales analyse mainly motor symptoms which might explain a similar result, regardless of the weak overlap of the questionnaires (0.31). On the other hand, Tomic et al. presented a significant correlation between disability measured by TWSTRS and subscales of CDQ-24 [32]. However, considering the very weak overlap between TWSTRS and CDQ-24 (0.15) the symptoms assessed by CDQ-24 might be overlooked while using only TWSTRS. As was shown by Jost et al. TWSTRS is the main scale used in randomized controlled trials regarding botulinum toxin efficacy which is in line with our literature review in which it was the most commonly used scale [30]. It indicates that the NMS assessed by other scales are not taken into consideration in such trials regardless of their probable influence on the results. Even though TWSTRS analyse motor symptoms extensively, it captures only 30% of symptoms overall.

BFMDRS has the lowest mean overlap (0.09), simultaneously having very weak or weak overlap with scales analysing mostly motor symptoms (e.g. TWSTRS) or NMS (e.g. DNMSQuest). Therefore, this scale should not be used alone but with e.g. Tsui scale or CDSS which evaluate most of motor symptoms while not considering disability assessed in BFMDRS. Instruments with very weak overlap, especially with an overlap which equals zero (e.g. Tsui scale and BFMDRS, Tsui scale and CDQ-24, CDQ-24 and CDSS) should not be used interchangeably as they examine entirely different symptoms.

Taking into consideration our original analysis of symptom categories, three types of scales might be identified – analysing motor symptoms, NMS or both. The first type consists of TWSTRS, Tsui scale and CDSS; the second – CDQ-24 and DNMSQuest; the third – CDIP-58 and BFMDRS. TWSTRS examines the highest number of motor symptoms and disability symptoms; CDIP-58 – of sensory symptoms, sleep disturbances and gait disturbances; CDQ-24 – of emotions and social interactions (however the differences between the number of symptoms analysed by CDQ-24 and CDIP-58 in those categories are small). CDIP-58 is the only scale that examines at least one symptom in each category. The suggested categorization is also supported by specific content overlap analysis. Motor symptoms scales have none or very weak overlap with nonmotor scales, while the overlap score is greater inside the type.

Based on our analysis, CDIP-58 examines the largest number of symptoms and has the highest mean overlap with other scales. Thus, it might be a valuable clinical tool. Furthermore, there is a moderate correlation between the Jaccard index and scale length, and CDIP-58 is the scale consisting of the greatest number of items in our study. However, it analyses a low number of specific motor symptoms. TWSTRS on the other hand is well validated and most commonly used to assess motor symptoms [30]. That is why in our opinion CDIP-58 should be combined with TWSTRS for complex assessment of CD.

Limitations

As in the previous studies using the content analysis, the main limitation is the number and choice of scales [17, 18]. As before, we implemented a thorough literature search to minimise the risk of bias resulting from wrong scale choice. Another limitation of content overlap analysis is the lack of an objective method to compare the items across the instruments [17, 18]. We followed Fried's (2017) methodology and if there were any doubts about the symptoms we considered symptoms rather too similar than too different [17].

Conclusions

It was the first study to conduct content overlap analysis of the CD symptoms scales. We showed a very weak overlap among scales and categorised the scales on the basis of assessed symptoms. None of the scales alone examines the CD symptoms exhaustively enough, which is why we recommend combining them.

Funding

No funding was received to assist with the preparation of this manuscript.

Data availability

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

Declarations

Ethical approval

This is a study based on the literature review. Therefore, no ethical approval is required.

Informed consent

This is a study based on the literature review. Therefore, no informed consent was obtained.

Competing interests

The authors have no relevant financial or non-financial interests to disclose.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Grütz K, Klein C. Dystonia updates: definition, nomenclature, clinical classification, and etiology. J Neural Transm. 2021;128:395–404. doi: 10.1007/s00702-021-02314-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol. 2009;8:844–856. doi: 10.1016/S1474-4422(09)70183-8. [DOI] [PubMed] [Google Scholar]
  • 3.Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VSC, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013;28:863–873. doi: 10.1002/mds.25475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Lungu C, Tarulli AW, Tarsy D, Mongiovi P, Vanderhorst VG, Rutkove SB. Quantifying muscle asymmetries in cervical dystonia with electrical impedance: a preliminary assessment. Clin Neurophysiol Off J Int Fed Clin Neurophysiol. 2011;122:1027–1031. doi: 10.1016/j.clinph.2010.09.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Consky ES, Lang AE. Clinical assessments of patients with cervical dystonia. In: Jancovic J, Hallett M, editors. Therapy with botulinum toxin. New York: Marcel Dekker; 1994. pp. 211–237. [Google Scholar]
  • 6.Tsui JKC, Jon Stoessl A, Eisen A, Calne S, Calne DB. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet. 1986;328:245–247. doi: 10.1016/S0140-6736(86)92070-2. [DOI] [PubMed] [Google Scholar]
  • 7.Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology. 1985;35:73–77. doi: 10.1212/wnl.35.1.73. [DOI] [PubMed] [Google Scholar]
  • 8.Cano SJ, Warner TT, Linacre JM, Bhatia KP, Thompson AJ, Fitzpatrick R, et al. Capturing the true burden of dystonia on patients: The Cervical Dystonia Impact Profile (CDIP-58) Neurology. 2004;63:1629–1633. doi: 10.1212/01.WNL.0000142962.11881.26. [DOI] [PubMed] [Google Scholar]
  • 9.Müller J, Wissel J, Kemmler G, Voller B, Bodner T, Schneider A, et al. Craniocervical dystonia questionnaire (CDQ-24): Development and validation of a disease-specific quality of life instrument. J Neurol Neurosurg Psychiatry. 2004;75:749–753. doi: 10.1136/jnnp.2003.013441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.O’Brien C, Brashear A, Cullis P, Truong D, Molho E, Jenkins S, et al. Cervical dystonia severity scale reliability study. Mov Disord. 2001;16:1086–1090. doi: 10.1002/mds.1226. [DOI] [PubMed] [Google Scholar]
  • 11.Dressler D, Paus S, Seitzinger A, Gebhardt B, Kupsch A. Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia. J Neurol Neurosurg Psychiatry. 2013;84:1014–1019. doi: 10.1136/jnnp-2012-303608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Klingelhoefer L, Chaudhuri KR, Kamm C, Martinez-Martin P, Bhatia K, Sauerbier A, et al. Validation of a self-completed dystonia non-motor symptoms questionnaire. Ann Clin Transl Neurol. 2019;6:2054–2065. doi: 10.1002/acn3.50900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Comella CL, Leurgans S, Wuu J, Glenn ST, Chmura T. Rating scales for dystonia: A multicenter assessment. Mov Disord. 2003;18:303–312. doi: 10.1002/mds.10377. [DOI] [PubMed] [Google Scholar]
  • 14.Torres JAKL, Rosales RL (2017) Nonmotor Symptoms in Dystonia. vol. 134. 1st ed. Elsevier Inc. 10.1016/bs.irn.2017.05.003 [DOI] [PubMed]
  • 15.Novaretti N, Cunha ALN, Bezerra TC, Pereira MAP, De Oliveira DS, Macruz Brito MMC, et al. The prevalence and correlation of non-motor symptoms in adult patients with idiopathic focal or segmental dystonia. Tremor Other Hyperkinet Mov. 2019;9:1–7. doi: 10.7916/fhnv-v355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Han V, Skorvanek M, Smit M, Turcanova Koprusakova M, Hoekstra T, van Dijk JP, et al. Prevalence of non-motor symptoms and their association with quality of life in cervical dystonia. Acta Neurol Scand. 2020;142:613–622. doi: 10.1111/ane.13304. [DOI] [PubMed] [Google Scholar]
  • 17.Fried EI. The 52 symptoms of major depression: Lack of content overlap among seven common depression scales. J Affect Disord. 2017;208:191–197. doi: 10.1016/j.jad.2016.10.019. [DOI] [PubMed] [Google Scholar]
  • 18.Chrobak AA, Krupa A, Dudek D, Siwek M. How soft are neurological soft signs? Content overlap analysis of 71 symptoms among seven most commonly used neurological soft signs scales. J Psychiatr Res. 2021;138:404–412. doi: 10.1016/j.jpsychires.2021.04.020. [DOI] [PubMed] [Google Scholar]
  • 19.Chrobak AA, Siwek M, Dudek D, Rybakowski JK. Content overlap analysis of 64 (hypo)mania symptoms among seven common rating scales. Int J Methods Psychiatr Res. 2018;27:e1737. doi: 10.1002/mpr.1737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Gauld C, Martin VP, Richaud A, Baillieul S, Vicente L, Perromat J-L et al (2023) Systematic Item Content and Overlap Analysis of Self-Reported Multiple Sleep Disorder Screening Questionnaires in Adults. J Clin Med 12. 10.3390/jcm12030852 [DOI] [PMC free article] [PubMed]
  • 21.Wall AD, Lee EB. What do anxiety scales really measure? An item content analysis of self-report measures of anxiety. J Psychopathol Behav Assess. 2022;44:1148–1157. doi: 10.1007/s10862-022-09973-9. [DOI] [Google Scholar]
  • 22.Comella CL, Stebbins GT, Goetz CG, Chmura TA, Bressman SB, Lang AE. Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. Mov Disord. 1997;12:570–575. doi: 10.1002/mds.870120414. [DOI] [PubMed] [Google Scholar]
  • 23.Cano SJ, Warner TT, Thompson AJ, Bhatia KP, Fitzpatrick R, Hobart JC. The cervical dystonia impact profile (CDIP-58): can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria? Health Qual Life Outcomes. 2008;6:58. doi: 10.1186/1477-7525-6-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Evans JD (1996) Straightforward statistics for the behavioral sciences. Thomson Brooks/Cole Publishing Co
  • 25.R Core Team (2022) R: A language and environment for statistical ## computing. R Foundation for Statistical Computing
  • 26.Saunders-Pullman R, Soto-Valencia J, Costan-Toth C, Shriberg J, Raymond D, Derby CA, et al. A new screening tool for cervical dystonia. Neurology. 2005;64:2046–2049. doi: 10.1212/01.WNL.0000166030.05756.9F. [DOI] [PubMed] [Google Scholar]
  • 27.Reichel G. Cervical dystonia: A new phenomenological classification for botulinum toxin therapy. Basal Ganglia. 2011;1:5–12. doi: 10.1016/j.baga.2011.01.001. [DOI] [Google Scholar]
  • 28.Cano SJ, Hobart JC, Fitzpatrick R, Bhatia K, Thompson AJ, Warner TT. Patient-based outcomes of cervical dystonia: A review of rating scales. Mov Disord. 2004;19:1054–1059. doi: 10.1002/mds.20055. [DOI] [PubMed] [Google Scholar]
  • 29.Albanese A, Del SF, Comella C, Jinnah HA, Mink JW, Post B, et al. Dystonia rating scales: Critique and recommendations. Mov Disord. 2013;28:874–883. doi: 10.1002/mds.25579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Jost WH, Hefter H, Stenner A, Reichel G. Rating scales for cervical dystonia: A critical evaluation of tools for outcome assessment of botulinum toxin therapy. J Neural Transm. 2013;120:487–496. doi: 10.1007/s00702-012-0887-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Tarsy D. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin. Mov Disord. 1997;12:100–102. doi: 10.1002/mds.870120117. [DOI] [PubMed] [Google Scholar]
  • 32.Tomic S, Petkovic I, Pucic T, Resan B, Juric S, Rotim T. Cervical dystonia and quality of life. Acta Neurol Belg. 2016;116:589–592. doi: 10.1007/s13760-016-0634-1. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.


Articles from Neurological Sciences are provided here courtesy of Springer

RESOURCES